List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Parkinson?s Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson?s Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson?s Disease Treatment Overall Market Size
2.1 Global Parkinson?s Disease Treatment Market Size: 2021 VS 2028
2.2 Global Parkinson?s Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Parkinson?s Disease Treatment Players in Global Market
3.2 Top Global Parkinson?s Disease Treatment Companies Ranked by Revenue
3.3 Global Parkinson?s Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Parkinson?s Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Parkinson?s Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson?s Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Parkinson?s Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Parkinson?s Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Parkinson?s Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Transdermal
4.1.4 Subcutaneous
4.1.5 Intestinal Infusion
4.2 By Type - Global Parkinson?s Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Parkinson?s Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Parkinson?s Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson?s Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Parkinson?s Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Parkinson?s Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Parkinson?s Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Parkinson?s Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Parkinson?s Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Parkinson?s Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Parkinson?s Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Parkinson?s Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Parkinson?s Disease Treatment Revenue, 2017-2028
6.3.2 US Parkinson?s Disease Treatment Market Size, 2017-2028
6.3.3 Canada Parkinson?s Disease Treatment Market Size, 2017-2028
6.3.4 Mexico Parkinson?s Disease Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Parkinson?s Disease Treatment Revenue, 2017-2028
6.4.2 Germany Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.3 France Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.4 U.K. Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.5 Italy Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.6 Russia Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Parkinson?s Disease Treatment Market Size, 2017-2028
6.4.8 Benelux Parkinson?s Disease Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Parkinson?s Disease Treatment Revenue, 2017-2028
6.5.2 China Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.3 Japan Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.4 South Korea Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Parkinson?s Disease Treatment Market Size, 2017-2028
6.5.6 India Parkinson?s Disease Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Parkinson?s Disease Treatment Revenue, 2017-2028
6.6.2 Brazil Parkinson?s Disease Treatment Market Size, 2017-2028
6.6.3 Argentina Parkinson?s Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Parkinson?s Disease Treatment Revenue, 2017-2028
6.7.2 Turkey Parkinson?s Disease Treatment Market Size, 2017-2028
6.7.3 Israel Parkinson?s Disease Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Parkinson?s Disease Treatment Market Size, 2017-2028
6.7.5 UAE Parkinson?s Disease Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Parkinson?s Disease Treatment Major Product Offerings
7.1.4 Teva Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.1.5 Teva Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Parkinson?s Disease Treatment Major Product Offerings
7.2.4 Roche Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Prothena
7.3.1 Prothena Corporate Summary
7.3.2 Prothena Business Overview
7.3.3 Prothena Parkinson?s Disease Treatment Major Product Offerings
7.3.4 Prothena Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.3.5 Prothena Key News
7.4 Acorda Therapeutics
7.4.1 Acorda Therapeutics Corporate Summary
7.4.2 Acorda Therapeutics Business Overview
7.4.3 Acorda Therapeutics Parkinson?s Disease Treatment Major Product Offerings
7.4.4 Acorda Therapeutics Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.4.5 Acorda Therapeutics Key News
7.5 Voyager Therapeutics
7.5.1 Voyager Therapeutics Corporate Summary
7.5.2 Voyager Therapeutics Business Overview
7.5.3 Voyager Therapeutics Parkinson?s Disease Treatment Major Product Offerings
7.5.4 Voyager Therapeutics Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.5.5 Voyager Therapeutics Key News
7.6 Impax Pharmaceuticals
7.6.1 Impax Pharmaceuticals Corporate Summary
7.6.2 Impax Pharmaceuticals Business Overview
7.6.3 Impax Pharmaceuticals Parkinson?s Disease Treatment Major Product Offerings
7.6.4 Impax Pharmaceuticals Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.6.5 Impax Pharmaceuticals Key News
7.7 UCB
7.7.1 UCB Corporate Summary
7.7.2 UCB Business Overview
7.7.3 UCB Parkinson?s Disease Treatment Major Product Offerings
7.7.4 UCB Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.7.5 UCB Key News
7.8 AbbVie
7.8.1 AbbVie Corporate Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Parkinson?s Disease Treatment Major Product Offerings
7.8.4 AbbVie Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.8.5 AbbVie Key News
7.9 MSD
7.9.1 MSD Corporate Summary
7.9.2 MSD Business Overview
7.9.3 MSD Parkinson?s Disease Treatment Major Product Offerings
7.9.4 MSD Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.9.5 MSD Key News
7.10 Orion Pharmaceuticals
7.10.1 Orion Pharmaceuticals Corporate Summary
7.10.2 Orion Pharmaceuticals Business Overview
7.10.3 Orion Pharmaceuticals Parkinson?s Disease Treatment Major Product Offerings
7.10.4 Orion Pharmaceuticals Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.10.5 Orion Pharmaceuticals Key News
7.11 Intec Pharma
7.11.1 Intec Pharma Corporate Summary
7.11.2 Intec Pharma Business Overview
7.11.3 Intec Pharma Parkinson?s Disease Treatment Major Product Offerings
7.11.4 Intec Pharma Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.11.5 Intec Pharma Key News
7.12 NeuroDerm
7.12.1 NeuroDerm Corporate Summary
7.12.2 NeuroDerm Business Overview
7.12.3 NeuroDerm Parkinson?s Disease Treatment Major Product Offerings
7.12.4 NeuroDerm Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.12.5 NeuroDerm Key News
7.13 Adamas Therapeutics
7.13.1 Adamas Therapeutics Corporate Summary
7.13.2 Adamas Therapeutics Business Overview
7.13.3 Adamas Therapeutics Parkinson?s Disease Treatment Major Product Offerings
7.13.4 Adamas Therapeutics Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.13.5 Adamas Therapeutics Key News
7.14 Acadia
7.14.1 Acadia Corporate Summary
7.14.2 Acadia Business Overview
7.14.3 Acadia Parkinson?s Disease Treatment Major Product Offerings
7.14.4 Acadia Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.14.5 Acadia Key News
7.15 Sunovion
7.15.1 Sunovion Corporate Summary
7.15.2 Sunovion Business Overview
7.15.3 Sunovion Parkinson?s Disease Treatment Major Product Offerings
7.15.4 Sunovion Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.15.5 Sunovion Key News
7.16 GSK
7.16.1 GSK Corporate Summary
7.16.2 GSK Business Overview
7.16.3 GSK Parkinson?s Disease Treatment Major Product Offerings
7.16.4 GSK Parkinson?s Disease Treatment Revenue in Global Market (2017-2022)
7.16.5 GSK Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
